DANBURY, Conn.--(BUSINESS WIRE)--IMS Health (NYSE:IMS) today announced the immediate availability of IMS Health Insights — a free application that delivers the company’s extensive thought leadership materials from 19 major countries directly to Apple and Android tablet devices.
Addressing the growing demand for easily accessible, global insights on critical healthcare topics, the new app enables decision makers in life sciences and healthcare to instantly locate and download IMS Health research and white papers that are based on the company’s extensive global information assets, sophisticated analytics and deep healthcare expertise.
“Our expert resources regularly create new insights and research important to industry leaders that underpins sound decision and policy making,” said Stefan Linn, senior vice president, Strategy & Commercial Operations, IMS Health. “With the IMS Health Insights app, we are making our thought leadership readily available to stakeholders looking for unbiased information and uncommon perspectives to enhance access to care, reduce healthcare costs and improve outcomes.”
In addition to offering access to featured presentations, the IMS Health Insights app enables users to filter thought leadership content by language, country and topic, and to easily share information across preferred social networks.
Content available on the app dates from the beginning of 2014 and is continually updated. Recent publications from IMS Health available through the new app include:
- Breaking New Ground with Real-World Evidence
- How Social Media Intelligence is Strengthening Pharma Strategy
- Supply Chain Optimization in Africa’s Private Sector
- Risks & Rewards in Pharmerging Markets: New Perspectives on Consumer Health
About IMS Health
IMS Health is a leading global information and technology services company providing clients in the healthcare industry with comprehensive solutions to measure and improve their performance. End-to-end proprietary applications and configurable solutions connect 10+ petabytes of complex healthcare data through the IMS OneTM cloud-based master data management platform, providing comprehensive insights into diseases, treatments, costs and outcomes. The company’s 15,000 employees blend global consistency and local market knowledge across 100 countries to help clients run their operations more efficiently. Customers include pharmaceutical, consumer health and medical device manufacturers and distributors, providers, payers, government agencies, policymakers, researchers and the financial community.
As a global leader in protecting individual patient privacy, IMS Health uses anonymous healthcare data to deliver critical, real-world disease and treatment insights. These insights help biotech and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders to identify unmet treatment needs and understand the effectiveness and value of pharmaceutical products in improving overall health outcomes. Additional information is available at www.imshealth.com.